Myriad Genetics
MYGN
MYGN
251 hedge funds and large institutions have $3.46B invested in Myriad Genetics in 2015 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 93 increasing their positions, 89 reducing their positions, and 50 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
18% less call options, than puts
Call options by funds: $22.1M | Put options by funds: $26.9M
36% less first-time investments, than exits
New positions opened: 32 | Existing positions closed: 50
Holders
251
Holding in Top 10
3
Calls
$22.1M
Puts
$26.9M
Top Buyers
| 1 | +$57.8M | |
| 2 | +$50.7M | |
| 3 | +$18.8M | |
| 4 |
DGI
Disciplined Growth Investors
Minneapolis,
Minnesota
|
+$17.5M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$16.2M |
Top Sellers
| 1 | -$59.5M | |
| 2 | -$57M | |
| 3 | -$37.5M | |
| 4 |
SCM
Snow Capital Management
Sewickley,
Pennsylvania
|
-$28.2M |
| 5 |
GAM
Gotham Asset Management
New York
|
-$19.4M |